Micron Biomedical
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
311 Ferst Dr NW Ste L1309, Atlanta, Geor...Website
www.micronbiomedical.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Micron Biomedical
Micron is an Atlanta based company whose microneedle technology was initially developed at Georgia Tech in the lab of Mark Prausnitz, PhD. Co-founded by Dr. Prausnitz, Dr. McAllister, and Sebastien Henry, MS, MBA, Micron has advanced the technology and emerged as a leader in dissolving microneedle-based vaccine and drug delivery technology. Micron's partners and funders include public and private vaccine and pharmaceutical companies, the Centers for Disease Control and Prevention (CDC), the Bill & Melinda Gates Foundation (funding Micron's MR vaccination activities), UNICEF, and the Georgia Research Alliance.Explore more
Micron Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Micron Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Micron Biomedical launches new products
Check out if Micron Biomedical is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Micron Biomedical has new funding data
Click to see if Micron Biomedical had a recent Job posting/layoffs
Earning: See what the market has to say on Micron Biomedical recently announced quarterly report
Check if Micron Biomedical has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Micron Biomedical
Micron Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Micron Biomedical
Compare insights from companies similar to Micron Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Micron Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Micron Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Micron Biomedical.
Micron Biomedical financials insights
Gather financial insights about Micron Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$17M
Micron Biomedical Tech Stack
A closer look at the technologies used by Micron Biomedical
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Bioengineering, Medical Research, Manufacturing Operations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Executive Move
Board of Directors
Funding
Micron Biomedical News & Media
Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure
NIH contracts Micron Biomedical to develop First Radiation Countermeasure with Dissolvable Microarray for Faster Deployment in emergency scenarios.Micron Biomedical Expands Leadership to Mobilize for Pivotal Studies and Commercialization of First Needle-Free Dissolvable Vaccines and Therapeutics
Elizabeth Holmberg brings extensive experience in capital formation, strategic partnerships, and scaling innovative healthcare companies to her role as Micron’s Chief Financial Officer Elizabeth Holmberg brings extensive experience in capital formation, strategic partnerships, and scaling innovative healthcare companies to her role as Micron’s Chief Financial OfficerMicron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia
National and local leaders across government, investors, life science industry and academia acknowledge the impact of Micron’s dissolvable vaccines and therapies on human health and economic development National and local leaders across government, investors, life science industry and academia acknowledge the impact of Micron’s dissolvable vaccines and therapies on human health and economic developmentMicron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered
Micron Biomedical makes the Most Innovative Companies List in recognition of clinical, financial and other progress toward needle-free vaccines and drugs.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Micron Biomedical
Sign Up For FreeTo access detailed company insights
Micron is an Atlanta based company whose microneedle technology was initially developed at Georgia Tech in the lab of Mark Prausnitz, PhD. Co-founded by Dr. Prausnitz, Dr. McAllister, and Sebastien Henry, MS, MBA, Micron has advanced the technology and emerged as a leader in dissolving microneedle-based vaccine and drug delivery technology. Micron'... Read More
